Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 16/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 15/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20599864 | 0.88 | HDAC4 (0.55) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL23931450 | 0.86 | HDAC4 (0.61) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL20640454 | 0.86 | HDAC4 (0.53) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL20600308 | 0.86 | HDAC4 (0.55) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL20599860 | 0.85 | HDAC6 (0.60) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL20654703 | 0.84 | HDAC6 (0.49) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL14645705 | 0.84 | HDAC4 (0.74) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL21407232 | 0.83 | HDAC6 (0.52) | HDAC4HDAC6HDAC1HDAC8 | |
| SCHEMBL20600408 | 0.83 | HDAC4 (0.67) | HDAC4HDAC6HDAC1HDAC3HDAC7 | |
| SCHEMBL22958916 | 0.83 | HDAC6 (0.55) | HDAC4HDAC6HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146643-B1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2024-05-29 | — | — | EP | disclosed |
| EP-4041721-B1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AG (DE) | 2024-03-06 | — | — | EP | disclosed |
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-02 | — | — | US | disclosed |
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230247986-A1 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES COMPRISING BIODEGRADABLE ESTER GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230242513-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230212163-A1 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| US-20230148601-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-18 | — | — | US | disclosed |
| EP-4172154-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | Bayer Animal Health GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-20230065953-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2023-03-02 | — | — | US | disclosed |
| EP-3929189-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | Bayer Animal Health GmbH (DE) | 2021-12-29 | — | — | EP | disclosed |
| EP-3845304-A1 | CAPSULE SUSPENSION CONCENTRATES BASED ON POLYISOCYANATES AND BIODEGRADABLE AMINE BASED CROSS-LINKER | Bayer AG (DE) | 2021-07-07 | — | — | EP | disclosed |
| WO-2021099303-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-05-27 | — | — | WO | disclosed |
| US-20210147371-A1 | OXADIAZOLINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-05-20 | — | — | US | disclosed |
| WO-2021097162-A1 | BENEFICIAL COMBINATIONS WITH PAENIBACILLUS | BAYER CROPSCIENCE LP (US) | 2021-05-20 | — | — | WO | disclosed |
| WO-2021069567-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2021-04-15 | — | — | WO | disclosed |
| EP-3774748-A1 | OXADIAZOLINE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2021-02-17 | — | — | EP | disclosed |
| WO-2020254490-A1 | PHENOXYPHENYL HYDROXYISOXAZOLINES AND ANALOGUES AS NEW ANTIFUNGAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-12-24 | — | — | WO | disclosed |
| WO-2020254489-A1 | BENZYLPHENYL HYDROXYISOXAZOLINES AND ANALOGUES AS NEW ANTIFUNGAL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-12-24 | — | — | WO | disclosed |
| WO-2019197371-A1 | OXADIAZOLINE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230065953-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | GLRX3, TARS2, CYP4F3 | HDAC4 1258/4885HDAC6 648/4885HDAC1 394/4885 |
| US-20230242513-A1 | NOVEL HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES | DDT, PRXL2A, CAT | HDAC4 2805/4885HDAC6 1737/4885HDAC1 843/4885 |
| US-20230348432-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | CYP4F3, CYP4X1, GLRX3 | HDAC4 1169/4885HDAC6 745/4885HDAC1 395/4885 |
| US-20230212163-A1 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | EPHX2, CYP8B1, CYP4X1 | HDAC4 1966/4885HDAC6 2399/4885HDAC1 868/4885 |
| US-20210147371-A1 | OXADIAZOLINE DERIVATIVES | DDT, FOXO3, PDCD4 | HDAC4 739/4885HDAC6 215/4885HDAC1 516/4885 |
| US-20230247986-A1 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES COMPRISING BIODEGRADABLE ESTER GROUPS | SRM, SMS, PARG | HDAC4 2170/4885HDAC6 882/4885HDAC1 1492/4885 |
| US-20230148601-A1 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | PRXL2A, GLRX3, CYP4F3 | HDAC4 1519/4885HDAC6 869/4885HDAC1 617/4885 |
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | CHRM1, DDT, H1-0 | HDAC4 681/4885HDAC6 287/4885HDAC1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.